HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Spondyloarthropathies: Targeted therapy for psoriatic arthritis.

Abstract
Tumor necrosis factor inhibitors are an effective treatment for psoriatic arthritis, but no single agent is effective in all patients. Novel therapies that target other cytokines have now been tested, with encouraging results.
AuthorsDafna D Gladman
JournalNature reviews. Rheumatology (Nat Rev Rheumatol) Vol. 5 Issue 5 Pg. 241-2 (May 2009) ISSN: 1759-4804 [Electronic] United States
PMID19412187 (Publication Type: Comment, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antirheumatic Agents
Topics
  • Antibodies, Monoclonal (administration & dosage, therapeutic use)
  • Antirheumatic Agents (administration & dosage, therapeutic use)
  • Arthritis, Psoriatic (drug therapy)
  • Clinical Trials, Phase III as Topic
  • Drug Delivery Systems
  • Drug Resistance
  • Drug Tolerance
  • Humans
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: